Does LEUPROLIDE Cause Hyperhidrosis? 878 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 878 reports of Hyperhidrosis have been filed in association with LEUPROLIDE (Fensolvi). This represents 1.2% of all adverse event reports for LEUPROLIDE.
878
Reports of Hyperhidrosis with LEUPROLIDE
1.2%
of all LEUPROLIDE reports
27
Deaths
120
Hospitalizations
How Dangerous Is Hyperhidrosis From LEUPROLIDE?
Of the 878 reports, 27 (3.1%) resulted in death, 120 (13.7%) required hospitalization, and 6 (0.7%) were considered life-threatening.
Is Hyperhidrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 878 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which LEUPROLIDE Alternatives Have Lower Hyperhidrosis Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM